research Inherited Ichthyoses: Generalized Mendelian Disorders of Cornification
Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.
Search
forLearn
0 / 0 results — no results
Research
5 / 1000+ results research Graft-Versus-Host Reaction: Cutaneous Manifestations Following Bone Marrow Transplantation
Skin changes help detect graft-versus-host reaction early after bone marrow transplants.
research Nutritional Dermatoses in Rats
Nutritional deficiencies in rats cause skin problems that can be treated with the right vitamins.
research Tinea Capitis in Adults
Adults with persistent scalp issues unresponsive to typical treatments should be tested for the fungal infection tinea capitis to start the right antifungal medication.
research Nutritional Skin Diseases in Goats
Some goats get rare skin diseases from not enough vitamin E, selenium, or zinc, but they're usually still healthy.
Community Join
5 / 44 resultscommunity Hair came back in 3 months at 39y/o.
A user shared their successful hair regrowth using a combination of minoxidil, caffeine, biotin, and RU58841, along with weekly dermarolling. However, others advised against the user's plan to switch to rosemary oil and microneedling only, emphasizing the importance of continuing the current treatment to maintain the results.
community Is hair thinning or loss associated with pain?
Hair thinning/loss associated with burning scalp pain. Finasteride helped relieve "DHT itch" for one person.
community Verteporfin update - donor hair regeneration human trial
A human trial of verteporfin, a potential treatment for hair loss, with some users noting potential improvements in scarring and overall healing compared to control areas.
community If follicles became miniaturized and haven’t grown in 3 years, are they dead ?
Hair loss and its potential treatments, such as minoxidil, finasteride, RU58841, dermarolling, and supplements. It discusses whether miniaturized follicles can be revived to grow again or must shed for new growth to appear.
community Phase II for Technoderma Therepeutic's TDM-105795 set to begin in April tentatively
Phase II for TDM-105795 for Androgenic Alopecia is set to begin in April 2023. The study aims to evaluate the efficacy and safety of TDM-105795 in male subjects.